You may also like
FDA Issues Public Health Advisory for Trasylol
The Food and Drug Administration today issued a Public Health Advisory alerting doctors who perform heart bypass surgery, and their patients, that Trasyolol (aprotinin injection), a drug used to prevent blood loss during surgery, has been linked in two scientific publications to higher risks of serious side effects including kidney problems, heart attacks and strokes in patients who undergo artery bypass graft surgery.
2 min read
Aprotinin for Open Cardiac Surgery in Cyanotic Heart Disease
ABSTRACT In a prospective randomized study, aprotinin was assessed in cyanotic children with tetralogy of Fallot undergoing total correction utilizing cardiopulmonary bypass. […]
1 min read